What question did this study set out to answer?

To evaluate advances in the diagnosis, clinical management, and pathogenesis of systemic lupus erythematosus, focusing on cutaneous manifestations, antiphospholipid syndrome, hormonal influences, and survival outcomes.

July 1, 1995Annals of Internal Medicine

Systemic Lupus Erythematosus: Emerging Concepts: Part 2: Dermatologic and Joint Disease, the Antiphospholipid Antibody Syndrome, Pregnancy and Hormonal Therapy, Morbidity and Mortality, and Pathogenesis

View Full Paper

Ask AI

Bookmark

Authors

DBDimitrios T. BoumpasNational and Kapodistrian University of Athens

Discussion

Member takes

Implication

Literature review uncovers evolving treatments and improved survival in systemic lupus erythematosus, highlighting ongoing morbidity from disease activity and therapies.

Key Points

To evaluate advances in the diagnosis, clinical management, and pathogenesis of systemic lupus erythematosus, focusing on cutaneous manifestations, antiphospholipid syndrome, hormonal influences, and survival outcomes.
Conducted a comprehensive review of more than 400 English-language articles, prioritizing literature published within the preceding 5 years.
Synthesized findings across dermatologic trials, retrospective evaluations of thrombosis management, and clinical data regarding pregnancy and exogenous estrogen exposure.
Survival outcomes improved substantially across recent cohorts, achieving 5-year survival rates of 90% or greater and 10-year survival rates exceeding 80%.
Retrospective and treatment-withdrawal data indicate warfarin provides superior thromboprotection compared with aspirin in anticardiolipin antibody syndrome, while hydroxychloroquine and retinoids showed equivalent therapeutic efficacy in uncontrolled cutaneous lupus trials.
Oral contraceptives and postmenopausal hormone replacement therapy were not linked to clinical exacerbations, whereas the precipitating role of pregnancy in disease flares remained inconclusive.

Cite This Study

Dimitrios T. Boumpas (1995) studied this question.

synapsesocial.com/papers/6a86e147fd179ab3599eb674 https://doi.org/10.7326/0003-4819-123-1-199507010-00007

View Full Paper

Ask AI

Bookmark

Implication

Literature review uncovers evolving treatments and improved survival in systemic lupus erythematosus, highlighting ongoing morbidity from disease activity and therapies.

Systemic Lupus Erythematosus: Emerging Concepts: Part 2: Dermatologic and Joint Disease, the Antiphospholipid Antibody Syndrome, Pregnancy and Hormonal Therapy, Morbidity and Mortality, and Pathogenesis

Discussion

Member takes

Implication

Key Points

Cite This Study

Systemic Lupus Erythematosus: Emerging Concepts: Part 2: Dermatologic and Joint Disease, the Antiphospholipid Antibody Syndrome, Pregnancy and Hormonal Therapy, Morbidity and Mortality, and Pathogenesis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider